FM
FMR LLC disclosed a 7.1% stake in SLN
FMR LLC reported owning 7.1% of Silence Therapeutics plc (SLN) (13,180,206 shares) in a Schedule 13G filed Nov 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 5, 2026
- Source
- Schedule 13G